- Full text PDF available (1)
- This year (0)
- Last five years (4)
Liver transplantation is an accepted treatment for end-stage liver disease due to hepatitis C (HCV), but remains controversial for patients with hepatitis B(HBV). Recently, the use of aggressive hepatitis B immunoglobulin (HBIg) to maintain hepatitis B surface antibody (anti-HBs) titers greater than 500 IU/L has been reported to improve outcome of… (More)
Research Reports, which record research conducted at IIASA, are independently reviewed before publication. Views and opinions expressed herein do not necessarily represent those of the Institute, its National Member Organizations, or other organizations supporting the work.